A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
Recruiting · NCT06815575 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours. | Advanced Solid Tumours; Solid Tumours | Recruiting | Phase 1 | 2026-06-02 | NCT06815575 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Racura Oncology Ltd | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Centre | Seoul | South Korea | 3 |
| Cancer Care Foundation | Miranda | Australia | 2 |
| Ewha womans university Mokdong Hospital | Seoul | South Korea | 11 |
| Gosford Hospital | Gosford | Australia | 18 |
| Prince of Wales Hospital | Shatin | Hong Kong | 48 |
| Queen Mary Hospital | Hong Kong | Hong Kong | 16 |
| Samsung Medical Centre | Seoul | South Korea | 1 |
| Severance Hospital, Yonsei University, Health System | Seoul | South Korea | 1 |
| Wyong Hospital | Wyong | Australia | 1 |